CETRELIMAB

UNII:	LYK98WP91F
Formula:
Preferred Substance Name:	CETRELIMAB
GSRS Full Record:	LYK98WP91F i

2050478-92-5
CETRELIMAB [INN]
CETRELIMAB [USAN]
CETRELIMAB [WHO-DD]
IMMUNOGLOBULIN G4, ANTI-(PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL JNJ-63723283 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JNJ-63723283 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH PROTEIN 1 (ANTIGEN CD279)) HUMAN MONOCLONAL ANTIBODY .GAMMA.4 HEAVY CHAIN (1-450) (HOMO SAPIENS VH (IGHV1-69*01 (99%) (IGHD)-IGHJ4*01 (93%)) (8.8.16) (1-123) -HOMO SAPIENS IGHG4*01 (HINGE(S10>P(231))) (124-450)) (137-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN (1'-214') (HOMO SAPIENS V-KAPPA (IGKV3-11*01 (97%) IGKJ1*01)(6.3.9) (1'-107') -HOMO SAPIENS IGKC*01 (108'-214')), DIMER (229-229'':232-232'')-BISDISULFIDE
JNJ63723283
JNJ-63723283

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

CETRELIMAB

Synonyms and Mappings

Resources